New York City, NY (PRWEB) October 31, 2012
Today, nonprofit organization Voices Against Brain Cancer (VABC) releases a statement following an article detailing new research that may help slow the progression of brain cancer and its recurrence.
According to RedOrbit.com, “Scientists have long believed that glioblastoma multiforme (GBM), the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. In a paper published October 18 in Science Express, however, researchers at the Salk Institute for Biological Studies have found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons.”
“GBM is one of the most devastating brain tumors that can affect humans. Despite progress in genetic analysis and classification, the prognosis of these tumors remains poor, with most patients dying within one to two years of diagnosis. The Salk researcher’s findings offer an explanation for the recurrence of GBM following treatment and suggest potential new targets to treat these deadly brain tumors,” explains the article. The article also states that the Salk scientists used genetically engineered mice to conduct their study. “The scientists say the tumors in their mouse model are similar to GBMs that affect humans. Because they have the same pathology and characteristic genetic signature, scientists can study potential therapies in mice that should, theoretically, work in humans. While they may not eradicate GBM, these therapies may slow the progression of the disease and improve patients’ quality of life,” RedOrbit.com reports.
VABC representative, Clay Darrohn, states, “All progress in the field of research when it comes to combatting this devastating disease is great. Even though the insights from this study may not eliminate the disease entirely, the fact that the hard work of researchers could improve the quality of life for patients and help not only those diagnosed, but also all of those affected by the disease is inspiring and gives hope.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC has a mission to find a cure for brain cancer by advancing scientific research, maximizing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: 5W Public Relations.